Spectranetics to Present at the JP Morgan 32nd Annual Healthcare Conference Print
Monday, 06 January 2014 10:05

COLORADO SPRINGS, Colo.--The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be presenting at the JP Morgan 32nd Annual Healthcare Conference on January 15th, 2014 in San Francisco.

Spectranetics' management is scheduled to present at 5:30 pm ET. Interested parties can access the live audio webcast at http://www.spectranetics.com. An archived presentation will be available on the Web site for 30 days.

About Spectranetics

Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are sold in over 40 countries and are used to treat arterial blockages in the heart and legs, and the removal of pacemaker and defibrillator leads.

The Company's Vascular Intervention (VI) products include a range of laser catheters for ablation of blockages in arteries above and below the knee. The Company also markets support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and

guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions. The Company markets aspiration and

Error. Page cannot be displayed. Please contact your service provider for more details. (13)

cardiac laser catheters to treat blockages in the heart.

The Lead Management (LM) product line includes excimer laser sheaths and

cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads. 

For more information, visit www.spectranetics.com.

CONTACT: COMPANY CONTACT          The Spectranetics Corporation          Guy Childs, Chief Financial Officer          (719) 633-8333                    INVESTOR CONTACTS          Westwicke Partners          Lynn Pieper          (415) 202-5678          lynn.pieper@westwicke.com

BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!